The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan.
Saved in:
| Title: | The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan. |
|---|---|
| Authors: | Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830-0011, Japan. shimose_shigeo@med.kurume-u.ac.jp., Saeki I; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Ito T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Takeuchi Y; Department of Gastroenterology, Okayama University Hospital, Okayama, Japan., Tani J; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Japan., Tomonari T; Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Japan., Sasaki R; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Sasaki K; Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Japan., Kakizaki S; Department of Clinical Research, NHO Takasaki General Medical Center, Takasaki, Gunma, Japan., Hatanaka T; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan., Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830-0011, Japan.; Iwamoto Internal Medical Clinic, Kitakyusyu, Japan., Tanabe N; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Yamamoto T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Naganuma A; Department of Clinical Research, NHO Takasaki General Medical Center, Takasaki, Gunma, Japan., Shirono T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830-0011, Japan., Kanayama Y; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan., Nishina S; Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Japan., Takayama T; Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Japan., Kobara H; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Japan., Otsuka M; Department of Gastroenterology, Okayama University Hospital, Okayama, Japan., Kawashima H; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Takami T; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830-0011, Japan. |
| Corporate Authors: | representing the Hepatology InVestigator Experts in Japan (HIVE-J) Study Group |
| Source: | Hepatology international [Hepatol Int] 2025 Aug; Vol. 19 (4), pp. 846-855. Date of Electronic Publication: 2025 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
